PBI14 COST-EFFECTIVENESS OF SECUKINUMAB VERSUS OTHER BIOLOGICS AND APREMILAST IN THE TREATMENT OF ACTIVE PSORIATIC ARTHRITIS: A SPANISH PERSPECTIVE
Abstract
Authors
J. Gratacós J.M. Martínez-Sesmero M. Jain A. Yocolly P. Gunda C. Blanch